These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 2967374

  • 1. Occurrence and pharmacological significance of metabolic ortho-hydroxylation of 5- and 8-hydroxy-2-(di-n-propylamino)tetralin.
    Wikström H, Elebring T, Hallnemo G, Andersson B, Svensson K, Carlsson A, Rollema H.
    J Med Chem; 1988 Jun; 31(6):1080-4. PubMed ID: 2967374
    [Abstract] [Full Text] [Related]

  • 2. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Johansson AM, Hacksell U, Nilsson JL, Svensson K, Hjorth S, Magnusson T, Carlsson A, Andersson B, Wikström H.
    J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
    [Abstract] [Full Text] [Related]

  • 3. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
    Mellin C, Björk L, Karlén A, Johansson AM, Sundell S, Kenne L, Nelson DL, Andén NE, Hacksell U.
    J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
    [Abstract] [Full Text] [Related]

  • 4. 8-Hydroxy-2-(di-n-propylamino)tetralin, a new centrally acting 5-hydroxytryptamine receptor agonist.
    Arvidsson LE, Hacksell U, Nilsson JL, Hjorth S, Carlsson A, Lindberg P, Sanchez D, Wikstrom H.
    J Med Chem; 1981 Aug; 24(8):921-3. PubMed ID: 6460101
    [No Abstract] [Full Text] [Related]

  • 5. Interactions of (+)- and (-)-8- and 7-hydroxy-2-(di-n-propylamino)tetralin at human (h)D3, hD2 and h serotonin1A receptors and their modulation of the activity of serotoninergic and dopaminergic neurones in rats.
    Lejeune F, Newman-Tancredi A, Audinot V, Millan MJ.
    J Pharmacol Exp Ther; 1997 Mar; 280(3):1241-9. PubMed ID: 9067310
    [Abstract] [Full Text] [Related]

  • 6. Testosterone increases the concentration of [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding [corrected] at 5-HT1A receptors in the medial preoptic nucleus of the castrated male rat.
    Mendelson SD, McEwen BS.
    Eur J Pharmacol; 1990 Jun 08; 181(3):329-31. PubMed ID: 2143479
    [No Abstract] [Full Text] [Related]

  • 7. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
    Gozlan H, Ponchant M, Daval G, Verge D, Menard F, Vanhove A, Beaucourt JP, Hamon M.
    J Pharmacol Exp Ther; 1988 Feb 08; 244(2):751-9. PubMed ID: 2964524
    [Abstract] [Full Text] [Related]

  • 8. N,N-di-n-propylserotonin: binding at serotonin binding sites and a comparison with 8-hydroxy-2-(di-n-propylamino)tetralin.
    Glennon RA, Titeler M, Lyon RA, Slusher RM.
    J Med Chem; 1988 Apr 08; 31(4):867-70. PubMed ID: 2965244
    [Abstract] [Full Text] [Related]

  • 9. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
    Millan MJ, Bervoets K, Colpaert FC.
    J Pharmacol Exp Ther; 1991 Mar 08; 256(3):973-82. PubMed ID: 1826033
    [Abstract] [Full Text] [Related]

  • 10. 8-Hydroxy-2-(di-n-propylamino)-tetralin discriminates between subtypes of the 5-HT1 recognition site.
    Middlemiss DN, Fozard JR.
    Eur J Pharmacol; 1983 May 20; 90(1):151-3. PubMed ID: 6223827
    [No Abstract] [Full Text] [Related]

  • 11. 5-Hydroxy-2-methyl-2-(di-n-propylamino)tetralin: synthesis and central pharmacological effects.
    Hacksell U, Arvidsson LE, Johansson AM, Nilsson JL, Sanchez D, Andersson B, Lindberg P, Wikström H, Hjorth S, Svensson K.
    Acta Pharm Suec; 1985 May 20; 22(2):65-74. PubMed ID: 2996294
    [No Abstract] [Full Text] [Related]

  • 12. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
    Arvidsson LE, Hacksell U, Johansson AM, Nilsson JL, Lindberg P, Sanchez D, Wikström H, Svensson K, Hjorth S, Carlsson A.
    J Med Chem; 1984 Jan 20; 27(1):45-51. PubMed ID: 6418888
    [Abstract] [Full Text] [Related]

  • 13. [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and postsynaptic 5-hydroxytryptamine sites in various regions of the rat brain.
    Hall MD, el Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H.
    J Neurochem; 1985 Jun 20; 44(6):1685-96. PubMed ID: 3157780
    [Abstract] [Full Text] [Related]

  • 14. Hippocampal 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding site densities, serotonin receptor (5-HT1A) messenger ribonucleic acid abundance, and serotonin levels parallel the activity of the hypothalamopituitary-adrenal axis in rat.
    Burnet PW, Mefford IN, Smith CC, Gold PW, Sternberg EM.
    J Neurochem; 1992 Sep 20; 59(3):1062-70. PubMed ID: 1379629
    [Abstract] [Full Text] [Related]

  • 15. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
    Arvidsson LE, Karlén A, Norinder U, Kenne L, Sundell S, Hacksell U.
    J Med Chem; 1988 Jan 20; 31(1):212-21. PubMed ID: 2961887
    [Abstract] [Full Text] [Related]

  • 16. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
    Björk L, Mellin C, Hacksell U, Andén NE.
    Eur J Pharmacol; 1987 Nov 03; 143(1):55-63. PubMed ID: 2961582
    [Abstract] [Full Text] [Related]

  • 17. Differential serotoninergic and dopaminergic activities of the (R)- and the (S)-enantiomers of 2-(di-n-propylamino)tetralin.
    Yu H, Liu Y, Malmberg A, Mohell N, Hacksell U, Lewander T.
    Eur J Pharmacol; 1996 May 15; 303(3):151-62. PubMed ID: 8813561
    [Abstract] [Full Text] [Related]

  • 18. Nucleotide interactions with 5-HT1A binding sites directly labeled by [3H]-8-hydroxy-2-(DI-n-propylamino)tetralin ([3H]-8-OH-DPAT).
    Schlegel JR, Peroutka SJ.
    Biochem Pharmacol; 1986 Jun 15; 35(12):1943-9. PubMed ID: 3013203
    [Abstract] [Full Text] [Related]

  • 19. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
    Hacksell U, Johansson AM, Arvidsson L, Nilsson JL, Hjorth S, Carlsson A, Wikström H, Sanchez D, Lindberg P.
    J Med Chem; 1984 Aug 15; 27(8):1003-7. PubMed ID: 6431102
    [Abstract] [Full Text] [Related]

  • 20. Binding of the novel serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin in normal and Alzheimer brain.
    Middlemiss DN, Palmer AM, Edel N, Bowen DM.
    J Neurochem; 1986 Mar 15; 46(3):993-6. PubMed ID: 2419502
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.